News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
India and Japan on Tuesday signed four agreements under which Tokyo is to support health care projects funded under the Grant Assistance for Grassroots Projects (GGP) scheme in India.
India’s drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source.
“Indian Army has gifted one lakh doses of made in India COVID – 19 vaccines to Nepal Army and it will be helpful for the force,” sources from the Indian Embassy in Kathmandu said.
The Council of Scientific and Industrial Research and Bharat Biotech International are looking at bringing the messenger RNA platform to India after seeing its successful use in quick development of covid-19 vaccines by US-based Pfizer and Moderna.
India shipped out 200,000 doses of COVID-19 vaccines on Saturday to inoculate UN blue helmets serving in peacekeeping missions.
Researchers showed that the biochemical working of this drug molecule points to its promise in the treatment of COVID-19. The paper elaborates on the rationale of repurposing this drug for treating COVID-19 patients. Since the repurposed drug has gone through the clinical development process for the treatment of other diseases and has already been tested for toxicity, many steps in preclinical and early clinical development can be avoided and the drug can be directly tested on COVID-19 subjects in phase-II trials.
National Pharmaceutical Pricing Authority (NPPA) NPPA fixes the price of 81 medicines including off-patent anti-diabetic drugs allowing due benefits of patent expiry to the patients.
The Department of Biotechnology (DBT) and Cancer Research UK (CRUK) signed a Memorandum of Understanding (MoU) for a Cancer Research Initiative, “Affordable Approaches to Cancer” on 14th November 2018 during the Inaugural Researcher’s Summit held from 14th – 16th November 2018 in New Delhi. The broad aim of the research initiative is to support high quality research to deliver innovative and translatable outputs that accelerate progress against cancer outcomes in both the countries, and which also have the potential to have major global impact.
The Ministry of AYUSH has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H). The Pharmacopoeia Commission has published 645 standards of Ayurveda Single drugs, 202 compound Ayurveda Drug, 298 Unani single drug & 150 Unani Compound drug, 139 Siddha drugs & 1117 Homoeopathic Drugs standards are published in the form of respective Pharmacopoeias.
Govt. of India’s National Telemedicine Service – eSanjeevani has crossed another milestone by completing 3 million (30 lakh) consultations. Currently, the National Telemedicine Service is operational in 31 States/Union Territories and daily over 35,000 patients across the country are using this innovative digital medium – eSanjeevani, to seek health services.
